Illumina told shareholders that Carl Icahn’s board nominees would “threaten the progress” of the biotech company’s core business.
Salesforce is appointing three new directors to its board, including ValueAct’s Mason Morfit.
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}